Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus

Published:2017-05 Issue: Volume:127 Page:181-186
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Lunder Mojca,Janić Miodrag,Savić Vedran,Janež Andrej,Kanc Karin,Šabovič Mišo

Funder

Slovenian Research Agency, Ljubljana, Slovenia

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference23 articles.

1. Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population;Lee;Ther Adv Chronic Dis,2015

2. Advanced glycation end products: a molecular target for vascular complications in diabetes;Yamagishi;Mol Med,2015

3. Durning SP, Preston-Hurlburt P, Clark PR, Xu D, Herold KC, Type 1 Diabetes TrialNet Study G. The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus. J Immunol, 2016.

4. Elevated serum levels of soluble TNF receptors and adhesion molecules are associated with diabetic retinopathy in patients with type-1 diabetes;Sharma;Mediators Inflamm,2015

5. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population;Aguilera;Cardiovasc Diabetol,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential role of statins in treatment of acute sarcopenia;Medical Hypotheses;2023-08

2. Efficacy and safety of sacubitril/valsartan in an outpatient setting: A single-center real-world retrospective study in HFrEF patients with focus on possible predictors of clinical outcome;Advances in Clinical and Experimental Medicine;2022-01-29

3. Attenuating the Variability of Lipids Is Beneficial for the Hypertension Management to Reduce the Cardiovascular Morbidity and Mortality in Older Adults;Frontiers in Cardiovascular Medicine;2021-06-17

4. Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs;International Journal of Molecular Sciences;2021-03-10

5. Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension;American Journal of Physiology-Renal Physiology;2020-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3